IQV
IQVIA Holdings, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #447
- Final score
- 52.26
- Years on list
- 6
↗ Climbed 48 since 2020
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- IQV· IQVIA Holdings, Inc.
- ALNY· Alnylam Pharmaceuticals, Inc.
- RGEN· Repligen Corporation
Figure 01 · Side-by-side summary
The headline numbers
ALNY
Alnylam Pharmaceuticals, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #445
- Final score
- 52.30
- Years on list
- 6
↗ Climbed 293 since 2020
RGEN
Repligen CorporationPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #478
- Final score
- 51.41
- Years on list
- 5
↗ Climbed 316 since 2021
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | IQV | ALNY | RGEN |
|---|---|---|---|
| Climate Change | 78.2 | 48.5 | 65.6 |
| Employee Relations | 47.8 | 63.5 | 37.8 |
| Environment | 36.7 | 61.1 | 57.0 |
| Stakeholders & Society | 63.1 | 48.7 | 49.6 |
| Human Rights | 23.2 | 31.7 | 52.4 |
| Governance | 55.4 | 42.1 | 38.6 |
| Performance Rating | 42.9 | 64.7 | 49.0 |